01 1Curia
01 1DEXTROAMPHETAMINE SULFATE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-03
Pay. Date : 2013-11-21
DMF Number : 16021
Submission : 2002-06-21
Status : Active
Type : II
20
Curia New York Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is DEXTROAMPHETAMINE SULFATE USP, with a corresponding US DMF Number 16021.
Remarkably, this DMF maintains an Active status since its submission on June 21, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 03, 2014, and payment made on November 21, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
